MMRGlobal Targets Phase 3 Biotech Companies to Combine Assets With Life Sciences Group
19 nov. 2012 08h35 HE
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwire - Nov 19, 2012) - MMRGlobal, Inc. (OTCBB: MMRF) today announced that through its wholly owned subsidiary, MMR Life Sciences Group, the Company plans on exploiting its...
Stereotactic Radiosurgery Shows Promise as a Therapeutic Option for Patients With Primary Renal Cancer
31 oct. 2012 07h05 HE
|
American Society for Radiation Oncology
BOSTON, Oct. 31, 2012 (GLOBE NEWSWIRE) -- The first trial of safety and toxicity shows promise for stereotactic radiosurgery as a therapeutic option for patients with localized primary renal cancer...
Intermediate-Risk Patients With Organ-Confined Prostate Cancer Have High Cancer-Free Survival Rate After Stereotactic Body Radiation Therapy
30 oct. 2012 16h00 HE
|
American Society for Radiation Oncology
BOSTON, Oct. 30, 2012 (GLOBE NEWSWIRE) -- Stereotactic body radiotherapy (SBRT) yields excellent cancer-free survival rates for intermediate-risk, organ-confined prostate cancer patients and results...
High Doses of Stereotactic Body Radiotherapy for Patients With Organ-Confined Prostate Cancer Shows High Relapse-Free Survival
30 oct. 2012 15h53 HE
|
American Society for Radiation Oncology
BOSTON, Oct. 30, 2012 (GLOBE NEWSWIRE) -- Patients with organ-confined prostate cancer have new treatment options using high doses of focused stereotactic body radiotherapy (SBRT) instead of...
Annual Prostate Cancer Screening Improves Quality-Adjusted Life Expectancy for High-Risk Patients Compared to Unscreened Patients
30 oct. 2012 13h42 HE
|
American Society for Radiation Oncology
BOSTON, Oct. 30, 2012 (GLOBE NEWSWIRE) -- Annual prostate-specific antigen (PSA) screening yields a greater quality-adjusted life expectancy (QALE) among patients who have a high-risk of developing...
'Clinical Trials in Georgia' Conference Highlights State's Offerings
30 oct. 2012 07h46 HE
|
Georgia Clinical Trials
ATLANTA, GA--(Marketwire - Oct 30, 2012) - The first-ever Clinical Trials in Georgia Conference offers an unprecedented opportunity to learn about the latest advances making clinical trials faster,...
Accelerated Partial Breast Irradiation Using 3-D Conformal External Beam Radiation Therapy is Associated With a Negative Cosmetic Outcome Compared to Whole Breast Irradiation in Some Breast Cancer Patients
29 oct. 2012 14h38 HE
|
American Society for Radiation Oncology
BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- Accelerated partial breast irradiation using 3-D conformal external beam radiation therapy is associated with a negative cosmetic outcome compared to whole...
Stereotactic Body Radiation Therapy Shows Advances for Inoperable, Non-Small Cell Lung Cancer Patients
29 oct. 2012 11h16 HE
|
American Society for Radiation Oncology
BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- Stereotactic body radiation therapy (SBRT) yielded higher overall survival rates and low toxicity for patients with inoperable, non-small cell lung cancer...
Radiation After Breast-Conserving Surgery Increases Cause-Specific Survival Rate for Older Women With Early-Stage Breast Cancer
29 oct. 2012 11h16 HE
|
American Society for Radiation Oncology
BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- Older women with early-stage, low-risk breast cancer who were treated with radiation therapy (RT) after breast-conserving surgery (BCS) showed higher cause-...
Combination of Surgery and Adjuvant Radiation Treatment Shows Improved Survival for Elderly Women With Early-Stage Breast Cancer
29 oct. 2012 11h15 HE
|
American Society for Radiation Oncology
BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- Elderly women with early-stage breast cancer who received adjuvant radiation therapy after lumpectomy surgery have improved cause-specific survival (CSS)...